Evaluation of clinical pharmacy services in a hematology/oncology outpatient setting

Sachin Shah, Jonathan Dowell, Shane Greene

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

BACKGROUND: The Veterans Affairs North Texas Health Care System in Dallas, TX, provides a unique opportunity for clinical pharmacists to work as providers. Even though clinical pharmacists are actively involved in patient care, many of their efforts remain undocumented, resulting in an underestimation of the importance of their services and missed opportunities for improvements and new directions. OBJECTIVE: To document and evaluate the services of a hematology/oncology clinical pharmacy in the outpatient setting. METHODS: Pendragon Forms 3.2 software was used to design the documentation template. The template was designed to collect diagnoses, supportive care issues, drug-specific interventions, and prescriptions written. This template was uploaded to the personal digital assistant (PDA) for documentation. Patient-specific information was documented in a password-protected PDA. Data collected from November 1, 2002, to October 31, 2003, were retrospectively analyzed. RESULTS: Clinical pharmacists were involved in 423 patient visits for chemotherapy follow-up or disease management. Cancer diagnoses included colorectal (n = 99), multiple myeloma (59), non-small cell lung (56), chronic lymphocytic leukemia (44), myelodysplastic syndromes (22), and chronic myelogenous leukemia (19). During the 423 patient visits, 342 supportive care issues were addressed including anemia (34%), pain management (22%), constipation/diarrhea (15%), and nausea/vomiting (8%). Major drug-specific interventions included drug addition (41%), discontinuation (23%), and adjustment (21%). Four hundred forty-five prescriptions were filled, of which 181 were new and 150 were refilled. CONCLUSIONS: This is the first study, as of July 25, 2006, to document considerable contribution of an outpatient clinical pharmacist in direct cancer patient care. Although the disease management and supportive care issues addressed here may differ based on institution and patient population, the results of our study show that clinical pharmacists have ever-growing roles in the management of these patients.

Original languageEnglish (US)
Pages (from-to)1527-1533
Number of pages7
JournalAnnals of Pharmacotherapy
Volume40
Issue number9
DOIs
StatePublished - Sep 2006

Fingerprint

Hospital Pharmacy Services
Hematology
Pharmacists
Outpatients
Handheld Computers
Disease Management
Documentation
Prescriptions
Patient Care
Pharmaceutical Preparations
Medical Oncology
Myelodysplastic Syndromes
Veterans
B-Cell Chronic Lymphocytic Leukemia
Constipation
Pain Management
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Multiple Myeloma
Nausea
Vomiting

Keywords

  • Hematology
  • Oncology
  • Outpatient
  • Pharmacy

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Evaluation of clinical pharmacy services in a hematology/oncology outpatient setting. / Shah, Sachin; Dowell, Jonathan; Greene, Shane.

In: Annals of Pharmacotherapy, Vol. 40, No. 9, 09.2006, p. 1527-1533.

Research output: Contribution to journalArticle

@article{e5061ca140bf4f658034df0eec47ddd6,
title = "Evaluation of clinical pharmacy services in a hematology/oncology outpatient setting",
abstract = "BACKGROUND: The Veterans Affairs North Texas Health Care System in Dallas, TX, provides a unique opportunity for clinical pharmacists to work as providers. Even though clinical pharmacists are actively involved in patient care, many of their efforts remain undocumented, resulting in an underestimation of the importance of their services and missed opportunities for improvements and new directions. OBJECTIVE: To document and evaluate the services of a hematology/oncology clinical pharmacy in the outpatient setting. METHODS: Pendragon Forms 3.2 software was used to design the documentation template. The template was designed to collect diagnoses, supportive care issues, drug-specific interventions, and prescriptions written. This template was uploaded to the personal digital assistant (PDA) for documentation. Patient-specific information was documented in a password-protected PDA. Data collected from November 1, 2002, to October 31, 2003, were retrospectively analyzed. RESULTS: Clinical pharmacists were involved in 423 patient visits for chemotherapy follow-up or disease management. Cancer diagnoses included colorectal (n = 99), multiple myeloma (59), non-small cell lung (56), chronic lymphocytic leukemia (44), myelodysplastic syndromes (22), and chronic myelogenous leukemia (19). During the 423 patient visits, 342 supportive care issues were addressed including anemia (34{\%}), pain management (22{\%}), constipation/diarrhea (15{\%}), and nausea/vomiting (8{\%}). Major drug-specific interventions included drug addition (41{\%}), discontinuation (23{\%}), and adjustment (21{\%}). Four hundred forty-five prescriptions were filled, of which 181 were new and 150 were refilled. CONCLUSIONS: This is the first study, as of July 25, 2006, to document considerable contribution of an outpatient clinical pharmacist in direct cancer patient care. Although the disease management and supportive care issues addressed here may differ based on institution and patient population, the results of our study show that clinical pharmacists have ever-growing roles in the management of these patients.",
keywords = "Hematology, Oncology, Outpatient, Pharmacy",
author = "Sachin Shah and Jonathan Dowell and Shane Greene",
year = "2006",
month = "9",
doi = "10.1345/aph.1H162",
language = "English (US)",
volume = "40",
pages = "1527--1533",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "9",

}

TY - JOUR

T1 - Evaluation of clinical pharmacy services in a hematology/oncology outpatient setting

AU - Shah, Sachin

AU - Dowell, Jonathan

AU - Greene, Shane

PY - 2006/9

Y1 - 2006/9

N2 - BACKGROUND: The Veterans Affairs North Texas Health Care System in Dallas, TX, provides a unique opportunity for clinical pharmacists to work as providers. Even though clinical pharmacists are actively involved in patient care, many of their efforts remain undocumented, resulting in an underestimation of the importance of their services and missed opportunities for improvements and new directions. OBJECTIVE: To document and evaluate the services of a hematology/oncology clinical pharmacy in the outpatient setting. METHODS: Pendragon Forms 3.2 software was used to design the documentation template. The template was designed to collect diagnoses, supportive care issues, drug-specific interventions, and prescriptions written. This template was uploaded to the personal digital assistant (PDA) for documentation. Patient-specific information was documented in a password-protected PDA. Data collected from November 1, 2002, to October 31, 2003, were retrospectively analyzed. RESULTS: Clinical pharmacists were involved in 423 patient visits for chemotherapy follow-up or disease management. Cancer diagnoses included colorectal (n = 99), multiple myeloma (59), non-small cell lung (56), chronic lymphocytic leukemia (44), myelodysplastic syndromes (22), and chronic myelogenous leukemia (19). During the 423 patient visits, 342 supportive care issues were addressed including anemia (34%), pain management (22%), constipation/diarrhea (15%), and nausea/vomiting (8%). Major drug-specific interventions included drug addition (41%), discontinuation (23%), and adjustment (21%). Four hundred forty-five prescriptions were filled, of which 181 were new and 150 were refilled. CONCLUSIONS: This is the first study, as of July 25, 2006, to document considerable contribution of an outpatient clinical pharmacist in direct cancer patient care. Although the disease management and supportive care issues addressed here may differ based on institution and patient population, the results of our study show that clinical pharmacists have ever-growing roles in the management of these patients.

AB - BACKGROUND: The Veterans Affairs North Texas Health Care System in Dallas, TX, provides a unique opportunity for clinical pharmacists to work as providers. Even though clinical pharmacists are actively involved in patient care, many of their efforts remain undocumented, resulting in an underestimation of the importance of their services and missed opportunities for improvements and new directions. OBJECTIVE: To document and evaluate the services of a hematology/oncology clinical pharmacy in the outpatient setting. METHODS: Pendragon Forms 3.2 software was used to design the documentation template. The template was designed to collect diagnoses, supportive care issues, drug-specific interventions, and prescriptions written. This template was uploaded to the personal digital assistant (PDA) for documentation. Patient-specific information was documented in a password-protected PDA. Data collected from November 1, 2002, to October 31, 2003, were retrospectively analyzed. RESULTS: Clinical pharmacists were involved in 423 patient visits for chemotherapy follow-up or disease management. Cancer diagnoses included colorectal (n = 99), multiple myeloma (59), non-small cell lung (56), chronic lymphocytic leukemia (44), myelodysplastic syndromes (22), and chronic myelogenous leukemia (19). During the 423 patient visits, 342 supportive care issues were addressed including anemia (34%), pain management (22%), constipation/diarrhea (15%), and nausea/vomiting (8%). Major drug-specific interventions included drug addition (41%), discontinuation (23%), and adjustment (21%). Four hundred forty-five prescriptions were filled, of which 181 were new and 150 were refilled. CONCLUSIONS: This is the first study, as of July 25, 2006, to document considerable contribution of an outpatient clinical pharmacist in direct cancer patient care. Although the disease management and supportive care issues addressed here may differ based on institution and patient population, the results of our study show that clinical pharmacists have ever-growing roles in the management of these patients.

KW - Hematology

KW - Oncology

KW - Outpatient

KW - Pharmacy

UR - http://www.scopus.com/inward/record.url?scp=33748319502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748319502&partnerID=8YFLogxK

U2 - 10.1345/aph.1H162

DO - 10.1345/aph.1H162

M3 - Article

C2 - 16882869

AN - SCOPUS:33748319502

VL - 40

SP - 1527

EP - 1533

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 9

ER -